Skip to main content

Table 2 Predictive performance of the nomogram to predict relatively poor quality of life among patients with spine metastases in the training and validation sets

From: A novel nomogram to stratify quality of life among advanced cancer patients with spinal metastatic disease after examining demographics, dietary habits, therapeutic interventions, and mental health status

Predictive metrics

Training set

Validation set

Brier

0.13

0.16

Brierscaled

48.96%

34.77%

AUROC (95% CI)

0.90 (0.84–0.96)

0.85 (0.78–0.93)

Discrimination slope (95% CI)

0.50 (0.41–0.58)

0.44 (0.33–0.56)

Accuracy

83.65%

79.81%

Sensitivity

84.91%

84.91%

Specificity

82.35%

74.51%

Recall

84.91%

84.91%

Youden index

1.67

1.59

Threshold

44.24%

32.07%

  1. AUROC area under the receiver operating characteristic curve, CI confident interval